Tag archives: Representations and Warranties Insurance

Representations and Warranties Insurance and COVID-19 Considerations

Photo of Jamie ParkerBy Jamie Parker on Posted in M&A
The use of representations and warranties insurance (RWI) has grown dramatically in recent years as buyers (and to a lesser extent, sellers) have increasingly relied on RWI to allocate risks and provide other benefits in M&A transactions. The COVID-19 pandemic and its economic impacts have led to significant uncertainty for buyers, as well as for … Continue reading

Dissecting MedTech M&A deals

Photo of Shreya Gupta (Toronto)By Shreya Gupta (Toronto) on Posted in M&A, Pharmaceuticals and life sciences
As we previously reported, this year has seen a surge in healthcare-related M&A. Many of these transactions are in the medical technology industry, or MedTech. While the industry’s healthy profit margins and opportunities for growth have driven a flurry of activity, the potential for large rewards from MedTech acquisitions also comes with unique obstacles: Regulatory compliance: … Continue reading

Key findings: 2018 SRS Acquiom Buy-Side Representations and Warranties Insurance (RWI) Deal Terms Study

Photo of Troy Ungerman (Toronto)By Troy Ungerman (Toronto) on Posted in M&A
SRS Acquiom recently published its first Buy-Side Representations and Warranties Insurance (RWI) Deal Terms Study. The study analyzed the terms of 588 private-target acquisitions that closed between 2015 and 2017, the majority of which are not required to be publicly disclosed. As Canadian M&A deals continue to use RWI at an increasing pace, insights from … Continue reading
LexBlog